When treatment for advanced ovarian cancer begins, some patients go straight to surgery while others receive several cycles of chemotherapy first. Giving chemotherapy before surgery is called neoadjuvant chemotherapy (NAC), and the operation that follows is known as interval debulking surgery. A different order does not mean a patient is receiving inferior care — both pathways are recognized parts of standard treatment.

When deciding on timing, the care team focuses most on one question: can a single operation remove as much visible cancer as possible? Ovarian cancer has often spread to several places in the abdomen by the time it is found, so the pattern and extent of spread matter more than the size of any one mass. A large but well-contained tumor may be operated on right away, while smaller deposits scattered across the diaphragm, bowel, and surrounding tissue may be safer to shrink with chemotherapy first.

It is natural to worry that operating after chemotherapy means going into surgery weakened. In practice, neoadjuvant chemotherapy often reduces tumor burden, eases fluid buildup (ascites), pain, and poor appetite, and gives the body a chance to recover some strength and nutrition before surgery. When the tumor responds well, the operation can be shorter, with less bleeding, fewer complications, and a better chance of leaving little or no cancer behind. Being offered chemotherapy first does not necessarily mean the disease is hopeless — it is a strategy aimed at a more complete and safer operation.

If concerns remain, ask the team specific questions: why not operate first, how many cycles before reassessing for surgery, what determines whether surgery is possible, and what can be done now to support nutrition and strength. Because spread and overall condition differ from person to person, comparing yourself with another patient is less reliable than getting an explanation tailored to your own situation.

This article is general information and does not replace individual medical care. Please discuss decisions about treatment order and timing with the clinicians who have directly assessed your condition.